Prevalence of hepatitis C virus infection in patients with end-stage renal disease in Latin America and the Caribbean: a systematic review and meta-analysis
Aim To estimate the prevalence of hepatitis C virus (HCV) infection in patients with end-stage renal disease (ESRD) undergoing hemodialysis in Latin America and the Caribbean (LAC). Materials and methods Observational studies published in Spanish, Portuguese, and English language by November 25, 202...
Gespeichert in:
| Veröffentlicht in: | Archives of virology 2022-12, Vol.167 (12), p.2653-2664 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2664 |
|---|---|
| container_issue | 12 |
| container_start_page | 2653 |
| container_title | Archives of virology |
| container_volume | 167 |
| creator | Huarez, Bertha Hernández-Vásquez, Akram Azañedo, Diego Vargas-Fernández, Rodrigo Comandé, Daniel Agüero-Palacios, Ysela |
| description | Aim
To estimate the prevalence of hepatitis C virus (HCV) infection in patients with end-stage renal disease (ESRD) undergoing hemodialysis in Latin America and the Caribbean (LAC).
Materials and methods
Observational studies published in Spanish, Portuguese, and English language by November 25, 2021, in PubMed, Embase, Web of Science, Scopus, SciELO, and LILACS were selected by two reviewers according to predefined eligibility criteria. Study quality was assessed using the US National Heart, Lung and Blood Institute tool for observational cohort and cross-sectional studies. A meta-analysis of proportions was performed using a random-effects model based on the DerSimonian and Laird method, using R. PROSPERO N°: CRD42018107403.
Results
A total of 20 studies were included in the narrative synthesis (15 from Brazil, two from Cuba, two from Argentina, and one from Peru). Only 17 studies were included in the meta-analysis (13 from Brazil, two from Argentina, one from Cuba, and one from Peru). The overall prevalence of HCV in ESRD patients undergoing hemodialysis in LAC was 11.3% (95% confidence interval [CI]: 8.9% - 13.9%;
I
2
: 99 %). In Brazil and Argentina, the prevalence was 6% and 26.1%, respectively. Prevalence after excluding poor-quality studies was 10.7%.
Conclusion
The prevalence of HCV in ESRD patients undergoing hemodialysis in LAC was 11.3%. The implementation of infection control measures in hemodialysis centers in LAC is required. It is also necessary to increase the number of studies on the subject in the ESRD population in most LAC countries. |
| doi_str_mv | 10.1007/s00705-022-05604-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2721636196</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2748910222</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-fd3f2774c919c32550b82bf4ef6eddd9a91264fc8a7fb289ba566116f4d0f02c3</originalsourceid><addsrcrecordid>eNp9kctu1DAUhi0EokPhBVggS2zYGHxJnIRdNSoXaSRYwNpynOOOq8QZfJyp5l14WJxOAYkFG9s65zu_LX-EvBT8reC8eYdl4TXjUjJea14x_YhsRKUka5uufUw2XJViq3l7QZ4h3nJeCqp-Si6UFl3d8mpDfn5NcLQjRAd09nQPB5tDDki39BjSgjREDy6HOZYTXZsQM9K7kPcU4sAw2xugCaId6RAQLMIK7goY6dUEKThLbRxo3gPd2hT6Hmx8Ty3FE2aYCufK-DHA3T02QbbMlrQTBnxOnng7Irx42C_J9w_X37af2O7Lx8_bqx1zqqkz84Pysmkq14nOKVnXvG9l7yvwGoZh6GwnpK68a23je9l2va21FkL7auCeS6cuyZtz7iHNPxbAbKaADsbRRpgXNLKRQq9_pgv6-h_0dl5See9KVW0nig1ZKHmmXJoRE3hzSGGy6WQEN6s7c3ZnCm3u3Zk1-tVD9NJPMPwZ-S2rAOoMYGnFG0h_7_5P7C-emaYg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2748910222</pqid></control><display><type>article</type><title>Prevalence of hepatitis C virus infection in patients with end-stage renal disease in Latin America and the Caribbean: a systematic review and meta-analysis</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Huarez, Bertha ; Hernández-Vásquez, Akram ; Azañedo, Diego ; Vargas-Fernández, Rodrigo ; Comandé, Daniel ; Agüero-Palacios, Ysela</creator><creatorcontrib>Huarez, Bertha ; Hernández-Vásquez, Akram ; Azañedo, Diego ; Vargas-Fernández, Rodrigo ; Comandé, Daniel ; Agüero-Palacios, Ysela</creatorcontrib><description>Aim
To estimate the prevalence of hepatitis C virus (HCV) infection in patients with end-stage renal disease (ESRD) undergoing hemodialysis in Latin America and the Caribbean (LAC).
Materials and methods
Observational studies published in Spanish, Portuguese, and English language by November 25, 2021, in PubMed, Embase, Web of Science, Scopus, SciELO, and LILACS were selected by two reviewers according to predefined eligibility criteria. Study quality was assessed using the US National Heart, Lung and Blood Institute tool for observational cohort and cross-sectional studies. A meta-analysis of proportions was performed using a random-effects model based on the DerSimonian and Laird method, using R. PROSPERO N°: CRD42018107403.
Results
A total of 20 studies were included in the narrative synthesis (15 from Brazil, two from Cuba, two from Argentina, and one from Peru). Only 17 studies were included in the meta-analysis (13 from Brazil, two from Argentina, one from Cuba, and one from Peru). The overall prevalence of HCV in ESRD patients undergoing hemodialysis in LAC was 11.3% (95% confidence interval [CI]: 8.9% - 13.9%;
I
2
: 99 %). In Brazil and Argentina, the prevalence was 6% and 26.1%, respectively. Prevalence after excluding poor-quality studies was 10.7%.
Conclusion
The prevalence of HCV in ESRD patients undergoing hemodialysis in LAC was 11.3%. The implementation of infection control measures in hemodialysis centers in LAC is required. It is also necessary to increase the number of studies on the subject in the ESRD population in most LAC countries.</description><identifier>ISSN: 0304-8608</identifier><identifier>EISSN: 1432-8798</identifier><identifier>DOI: 10.1007/s00705-022-05604-6</identifier><identifier>PMID: 36195804</identifier><language>eng</language><publisher>Vienna: Springer Vienna</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Cross-Sectional Studies ; End-stage renal disease ; Hemodialysis ; Hepacivirus - genetics ; Hepatitis C ; Hepatitis C - complications ; Hepatitis C - epidemiology ; Humans ; Infections ; Infectious Diseases ; Kidney diseases ; Kidney Failure, Chronic - complications ; Kidney Failure, Chronic - epidemiology ; Latin America - epidemiology ; Medical Microbiology ; Meta-analysis ; Original Article ; Prevalence ; Virology</subject><ispartof>Archives of virology, 2022-12, Vol.167 (12), p.2653-2664</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-fd3f2774c919c32550b82bf4ef6eddd9a91264fc8a7fb289ba566116f4d0f02c3</citedby><cites>FETCH-LOGICAL-c375t-fd3f2774c919c32550b82bf4ef6eddd9a91264fc8a7fb289ba566116f4d0f02c3</cites><orcidid>0000-0002-7111-5169 ; 0000-0002-4938-3474 ; 0000-0001-6067-1218 ; 0000-0003-1375-8788 ; 0000-0002-3310-8689 ; 0000-0003-1431-2526</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00705-022-05604-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00705-022-05604-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36195804$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huarez, Bertha</creatorcontrib><creatorcontrib>Hernández-Vásquez, Akram</creatorcontrib><creatorcontrib>Azañedo, Diego</creatorcontrib><creatorcontrib>Vargas-Fernández, Rodrigo</creatorcontrib><creatorcontrib>Comandé, Daniel</creatorcontrib><creatorcontrib>Agüero-Palacios, Ysela</creatorcontrib><title>Prevalence of hepatitis C virus infection in patients with end-stage renal disease in Latin America and the Caribbean: a systematic review and meta-analysis</title><title>Archives of virology</title><addtitle>Arch Virol</addtitle><addtitle>Arch Virol</addtitle><description>Aim
To estimate the prevalence of hepatitis C virus (HCV) infection in patients with end-stage renal disease (ESRD) undergoing hemodialysis in Latin America and the Caribbean (LAC).
Materials and methods
Observational studies published in Spanish, Portuguese, and English language by November 25, 2021, in PubMed, Embase, Web of Science, Scopus, SciELO, and LILACS were selected by two reviewers according to predefined eligibility criteria. Study quality was assessed using the US National Heart, Lung and Blood Institute tool for observational cohort and cross-sectional studies. A meta-analysis of proportions was performed using a random-effects model based on the DerSimonian and Laird method, using R. PROSPERO N°: CRD42018107403.
Results
A total of 20 studies were included in the narrative synthesis (15 from Brazil, two from Cuba, two from Argentina, and one from Peru). Only 17 studies were included in the meta-analysis (13 from Brazil, two from Argentina, one from Cuba, and one from Peru). The overall prevalence of HCV in ESRD patients undergoing hemodialysis in LAC was 11.3% (95% confidence interval [CI]: 8.9% - 13.9%;
I
2
: 99 %). In Brazil and Argentina, the prevalence was 6% and 26.1%, respectively. Prevalence after excluding poor-quality studies was 10.7%.
Conclusion
The prevalence of HCV in ESRD patients undergoing hemodialysis in LAC was 11.3%. The implementation of infection control measures in hemodialysis centers in LAC is required. It is also necessary to increase the number of studies on the subject in the ESRD population in most LAC countries.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cross-Sectional Studies</subject><subject>End-stage renal disease</subject><subject>Hemodialysis</subject><subject>Hepacivirus - genetics</subject><subject>Hepatitis C</subject><subject>Hepatitis C - complications</subject><subject>Hepatitis C - epidemiology</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious Diseases</subject><subject>Kidney diseases</subject><subject>Kidney Failure, Chronic - complications</subject><subject>Kidney Failure, Chronic - epidemiology</subject><subject>Latin America - epidemiology</subject><subject>Medical Microbiology</subject><subject>Meta-analysis</subject><subject>Original Article</subject><subject>Prevalence</subject><subject>Virology</subject><issn>0304-8608</issn><issn>1432-8798</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kctu1DAUhi0EokPhBVggS2zYGHxJnIRdNSoXaSRYwNpynOOOq8QZfJyp5l14WJxOAYkFG9s65zu_LX-EvBT8reC8eYdl4TXjUjJea14x_YhsRKUka5uufUw2XJViq3l7QZ4h3nJeCqp-Si6UFl3d8mpDfn5NcLQjRAd09nQPB5tDDki39BjSgjREDy6HOZYTXZsQM9K7kPcU4sAw2xugCaId6RAQLMIK7goY6dUEKThLbRxo3gPd2hT6Hmx8Ty3FE2aYCufK-DHA3T02QbbMlrQTBnxOnng7Irx42C_J9w_X37af2O7Lx8_bqx1zqqkz84Pysmkq14nOKVnXvG9l7yvwGoZh6GwnpK68a23je9l2va21FkL7auCeS6cuyZtz7iHNPxbAbKaADsbRRpgXNLKRQq9_pgv6-h_0dl5See9KVW0nig1ZKHmmXJoRE3hzSGGy6WQEN6s7c3ZnCm3u3Zk1-tVD9NJPMPwZ-S2rAOoMYGnFG0h_7_5P7C-emaYg</recordid><startdate>20221201</startdate><enddate>20221201</enddate><creator>Huarez, Bertha</creator><creator>Hernández-Vásquez, Akram</creator><creator>Azañedo, Diego</creator><creator>Vargas-Fernández, Rodrigo</creator><creator>Comandé, Daniel</creator><creator>Agüero-Palacios, Ysela</creator><general>Springer Vienna</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7111-5169</orcidid><orcidid>https://orcid.org/0000-0002-4938-3474</orcidid><orcidid>https://orcid.org/0000-0001-6067-1218</orcidid><orcidid>https://orcid.org/0000-0003-1375-8788</orcidid><orcidid>https://orcid.org/0000-0002-3310-8689</orcidid><orcidid>https://orcid.org/0000-0003-1431-2526</orcidid></search><sort><creationdate>20221201</creationdate><title>Prevalence of hepatitis C virus infection in patients with end-stage renal disease in Latin America and the Caribbean: a systematic review and meta-analysis</title><author>Huarez, Bertha ; Hernández-Vásquez, Akram ; Azañedo, Diego ; Vargas-Fernández, Rodrigo ; Comandé, Daniel ; Agüero-Palacios, Ysela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-fd3f2774c919c32550b82bf4ef6eddd9a91264fc8a7fb289ba566116f4d0f02c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cross-Sectional Studies</topic><topic>End-stage renal disease</topic><topic>Hemodialysis</topic><topic>Hepacivirus - genetics</topic><topic>Hepatitis C</topic><topic>Hepatitis C - complications</topic><topic>Hepatitis C - epidemiology</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious Diseases</topic><topic>Kidney diseases</topic><topic>Kidney Failure, Chronic - complications</topic><topic>Kidney Failure, Chronic - epidemiology</topic><topic>Latin America - epidemiology</topic><topic>Medical Microbiology</topic><topic>Meta-analysis</topic><topic>Original Article</topic><topic>Prevalence</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huarez, Bertha</creatorcontrib><creatorcontrib>Hernández-Vásquez, Akram</creatorcontrib><creatorcontrib>Azañedo, Diego</creatorcontrib><creatorcontrib>Vargas-Fernández, Rodrigo</creatorcontrib><creatorcontrib>Comandé, Daniel</creatorcontrib><creatorcontrib>Agüero-Palacios, Ysela</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huarez, Bertha</au><au>Hernández-Vásquez, Akram</au><au>Azañedo, Diego</au><au>Vargas-Fernández, Rodrigo</au><au>Comandé, Daniel</au><au>Agüero-Palacios, Ysela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of hepatitis C virus infection in patients with end-stage renal disease in Latin America and the Caribbean: a systematic review and meta-analysis</atitle><jtitle>Archives of virology</jtitle><stitle>Arch Virol</stitle><addtitle>Arch Virol</addtitle><date>2022-12-01</date><risdate>2022</risdate><volume>167</volume><issue>12</issue><spage>2653</spage><epage>2664</epage><pages>2653-2664</pages><issn>0304-8608</issn><eissn>1432-8798</eissn><abstract>Aim
To estimate the prevalence of hepatitis C virus (HCV) infection in patients with end-stage renal disease (ESRD) undergoing hemodialysis in Latin America and the Caribbean (LAC).
Materials and methods
Observational studies published in Spanish, Portuguese, and English language by November 25, 2021, in PubMed, Embase, Web of Science, Scopus, SciELO, and LILACS were selected by two reviewers according to predefined eligibility criteria. Study quality was assessed using the US National Heart, Lung and Blood Institute tool for observational cohort and cross-sectional studies. A meta-analysis of proportions was performed using a random-effects model based on the DerSimonian and Laird method, using R. PROSPERO N°: CRD42018107403.
Results
A total of 20 studies were included in the narrative synthesis (15 from Brazil, two from Cuba, two from Argentina, and one from Peru). Only 17 studies were included in the meta-analysis (13 from Brazil, two from Argentina, one from Cuba, and one from Peru). The overall prevalence of HCV in ESRD patients undergoing hemodialysis in LAC was 11.3% (95% confidence interval [CI]: 8.9% - 13.9%;
I
2
: 99 %). In Brazil and Argentina, the prevalence was 6% and 26.1%, respectively. Prevalence after excluding poor-quality studies was 10.7%.
Conclusion
The prevalence of HCV in ESRD patients undergoing hemodialysis in LAC was 11.3%. The implementation of infection control measures in hemodialysis centers in LAC is required. It is also necessary to increase the number of studies on the subject in the ESRD population in most LAC countries.</abstract><cop>Vienna</cop><pub>Springer Vienna</pub><pmid>36195804</pmid><doi>10.1007/s00705-022-05604-6</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-7111-5169</orcidid><orcidid>https://orcid.org/0000-0002-4938-3474</orcidid><orcidid>https://orcid.org/0000-0001-6067-1218</orcidid><orcidid>https://orcid.org/0000-0003-1375-8788</orcidid><orcidid>https://orcid.org/0000-0002-3310-8689</orcidid><orcidid>https://orcid.org/0000-0003-1431-2526</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0304-8608 |
| ispartof | Archives of virology, 2022-12, Vol.167 (12), p.2653-2664 |
| issn | 0304-8608 1432-8798 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2721636196 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Biomedical and Life Sciences Biomedicine Cross-Sectional Studies End-stage renal disease Hemodialysis Hepacivirus - genetics Hepatitis C Hepatitis C - complications Hepatitis C - epidemiology Humans Infections Infectious Diseases Kidney diseases Kidney Failure, Chronic - complications Kidney Failure, Chronic - epidemiology Latin America - epidemiology Medical Microbiology Meta-analysis Original Article Prevalence Virology |
| title | Prevalence of hepatitis C virus infection in patients with end-stage renal disease in Latin America and the Caribbean: a systematic review and meta-analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T20%3A51%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20hepatitis%20C%20virus%20infection%20in%20patients%20with%20end-stage%20renal%20disease%20in%20Latin%20America%20and%20the%20Caribbean:%20a%20systematic%20review%20and%20meta-analysis&rft.jtitle=Archives%20of%20virology&rft.au=Huarez,%20Bertha&rft.date=2022-12-01&rft.volume=167&rft.issue=12&rft.spage=2653&rft.epage=2664&rft.pages=2653-2664&rft.issn=0304-8608&rft.eissn=1432-8798&rft_id=info:doi/10.1007/s00705-022-05604-6&rft_dat=%3Cproquest_cross%3E2748910222%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2748910222&rft_id=info:pmid/36195804&rfr_iscdi=true |